We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Note |

Debating Effect Sizes Comment on “Variations in Pill Appearance of Antiepileptic Drugs and the Risk of Nonadherence”

Kenneth E. Covinsky, MD, MPH
JAMA Intern Med. 2013;173(3):209. doi:10.1001/jamainternmed.2013.1545.
Text Size: A A A
Published online


In our discussion of the article by Kesselheim and coauthors, the editors debated the clinical implications of the findings. Some noted that the association between color change and nonpersistence with generic medicines was small. Color discordance preceded 1.20% of episodes of nonpersistence compared with 0.97% of episodes of persistence. This seems like a small effect: an absolute difference of 0.23%, slightly less than 1 out of 400.

However, others noted that over time, this seemingly small effect size could become quite important. Most patients refill a medicine at least 4 times a year. Over the course of several years, the risk of nonadherence owing to color change can add up even for 1 medicine. And consider the very common situation of an older patient dealing with a confusing regimen of many medicines. If they are taking 9 medicines, they get at least 36 “opportunities” a year to experience a color change. This seemingly small risk then starts to appear very substantial. Throw in some cognitive impairment and other sources of confusion, such as changing medication regimens each time a patient transitions in and out of the hospital, and it becomes easy to imagine how a medication color change can lead to a significant medication-related adverse event.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...